Evaluation of antinociceptive and anti-inflammatory effects of venlafaxine in the rat

Agri

Volumn 17, Issue 4, 2005, Pages 41-46

  Aricioǧlu, Feyza ^a   Buldanlioǧlu, Ulaş ^a,b   Salanturoǧlu, Gamze ^a,b   Özyalçin, Nuri Süleyman ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Anti inflammatory; Antinociceptive; Rat; Venlafaxine

Indexed keywords

CARRAGEENAN; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; INFLAMMATION; MECHANICAL STIMULATION; NONHUMAN; PAIN; RAT;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; CYCLOHEXANOLS; DISEASE MODELS, ANIMAL; EDEMA; FEMALE; MALE; MICE; MICE, INBRED BALB C; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33645449933     PISSN: 13000012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Adelman L. C., Adelman J. U., Von Seggern R., Mannix L. K.: Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting. Headache 2000; 40: 572-580.
2. Davis J. L., Smith R. L.: Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules. Diabetes Care 1999; 22: 1909-1910.
3. Diamond S., Pepper B. J., Diamond M. L., Freitag F. G., Urban G. J., Erdemoglu A. K.: Serotonin syndrome induced by transitioning from phenelzine to venlafaxine: four patient reports. Neurology. 1998; 51: 274-276.
4. Dwight M. M., Arnold L. M., O'Brien H., Metzger R., Morris-Park E., Keck P. E. Jr.: An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics 1998; 39: 14-17.
5. Enggaard T. P., Klitgaard N. A., Gram L. F., Arendt-Nielsen L., Sindrup S. H.: Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans. Clin Pharmacol Ther 2001; 69: 245-251.
6. Jones C. K., Peters S. C., Shannon H. E.: Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents. J Pharmacol Exp Ther 2005; 312: 726-732.
7. Kiayias J. A., Vlachou E. D., Lakka-Papadodima E.: Venlafaxine HCl in the treatment of painful peripheral diabetic neuropathy. Diabetes Care 2000; 23: 699.
8. Kvinesdal B., Molin J., Froland A., Gram L. F.: Imipramine treatment of painful diabetic neuropathy. JAMA 1984; 251: 1727-1730.
9. Lang E., Hord A. H., Denson D.: Venlafaxine hydrochloride (Effexor) relieves thermal hyperalgesia in rats with an experimental mononeuropathy. Pain 1996; 68: 151-155.
10. Lithner F.: Venlafaxine in treatment of severe painful peripheral diabetic neuropathy. Diabetes Care 2000; 23: 1710-1711.
11. Marchand F., Alloui A., Pelissier T., Hernandez A., Authier N., Alvarez P., Eschalier A., Ardid D.: Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat. Brain Res 2003; 980: 117-120.
12. Marchand F., Alloui A., Chapuy E., Jourdan D., Pelissier T., Ardid D., Hernandez A., Eschalier A.: Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats. Pain 2003; 103: 229-235.
13. McQuay H. J., Tramer M., Nye B. A., Carroll D., Wiffen P. J., Moore R. A.: A systematic review of antidepressants in neuropathic pain. Pain 1996; 68: 217-227.
14. Muth E. A., Haskins J. T., Moyer J. A., Husbands G. E., Nielsen S. T., Sigg E. B.: Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 1986; 35: 4493-4497.
15. Ozyalcin S. N., Talu G. K., Kiziltan E., Yucel B., Ertas M., Disci R.: The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache 2005; 45: 144-152.
16. Reuben S. S., Makari-Judson G., Lurie S. D.: Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of postmastectomy pain syndrome. J Pain Symptom Manage 2004; 27: 133-139.
17. Schreiber S., Backer M. M., Pick C. G.: The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms. Neurosci Lett 1999; 273: 85-88.
18. Sindrup S. H., Otto M., Finnerup N. B., Jensen T. S.: Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol. 2005; 96: 399-409.
19. Spiegel K., Kalb R., Pasternak G. W.: Analgesic activity of tricyclic antidepressants. Ann Neurol 1983; 13: 462-465.
20. Tura B., Tura S. M.: The analgesic effect of tricyclic antidepressants. Brain Res 1990; 518: 19-22.
21. Uyar M., Onal A., Uyar M., Dogru A., Soykan N.: The antinociceptive effect of tramadol-venlafaxine combination on the paw withdrawal threshold in a rat model of neuropathic pain. Methods Find Exp Clin Pharmacol 2003; 25: 361-365.